To select the appropriate cells for the analysis of ADCC function in canine NK cells and confirm the antitumor effects of trastuzumab and cetuximab on canine tumor cells, the surface expression of HER-2 and/or EGFR was first investigated in canine tumor cell lines by flow cytometry. The gene discussed is EGFR; the disease is neoplasm.